Stessman, H., Mansoor, A., Zhan, F., Janz, S., Linden, M., Baughn, L., & Van Ness, B. (2013). Reduced CXCR4 expression is associated with extramedullary disease in a mouse model of myeloma and predicts poor survival in multiple myeloma patients treated with bortezomib.

Stessman, HAF, A. Mansoor, F. Zhan, S. Janz, MA Linden, LB Baughn, and B. Van Ness. Reduced CXCR4 Expression Is Associated With Extramedullary Disease in a Mouse Model of Myeloma and Predicts Poor Survival in Multiple Myeloma Patients Treated With Bortezomib. 2013.

Stessman, HAF, et al. Reduced CXCR4 Expression Is Associated With Extramedullary Disease in a Mouse Model of Myeloma and Predicts Poor Survival in Multiple Myeloma Patients Treated With Bortezomib. 2013.